Melanoma, Secondary cancers
Open
Phase 2
This trial is looking at adding SCIB1 or iSCIB1+ to nivolumab and ipilimumab for melanoma. It is also looking at adding SCIB1 to pembrolizumab for melanoma.
It is for people whose melanoma has grown into surrounding tissues or spread elsewhere in the body. This is advanced melanoma.
Recruitment start: 19 August 2019
Recruitment end: 31 December 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Poulam Patel
Scancell Ltd
Last reviewed: 08 Apr 2025
CRUK internal database number: 16281
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
